Scarica l'app Stockscreener
6.48
1.22%
-0.08
Dopo l'orario di chiusura:
6.48
Precedente Chiudi:
$6.56
Aprire:
$6.54
Volume 24 ore:
316.08K
Relative Volume:
0.77
Capitalizzazione di mercato:
$430.01M
Reddito:
$555.06M
Utile/perdita netta:
$-39.48M
Rapporto P/E:
-10.80
EPS:
-0.6
Flusso di cassa netto:
$29.05M
1 W Prestazione:
-0.77%
1M Prestazione:
-14.29%
6M Prestazione:
-47.27%
1 anno Prestazione:
-4.42%
Intervallo 1D:
$6.35
$6.72
Intervallo di 1 settimana:
$6.35
$6.72
Portata 52W:
$5.28
$14.38
Bioventus Inc Stock (BVS) Company Profile
Nome
Bioventus Inc
Settore
Industria
Telefono
(919) 474-6700
Indirizzo
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Confronta BVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.48 | 433.32M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2022-11-22 | Downgrade | Craig Hallum | Buy → Hold |
| 2022-11-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Downgrade | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Iniziato | Craig Hallum | Buy |
| 2021-11-15 | Ripresa | Morgan Stanley | Overweight |
| 2021-11-10 | Ripresa | JP Morgan | Overweight |
| 2021-07-01 | Downgrade | Goldman | Buy → Neutral |
| 2021-03-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-03-08 | Iniziato | Goldman | Buy |
| 2021-03-08 | Iniziato | JP Morgan | Overweight |
| 2021-03-08 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Bioventus Inc Borsa (BVS) Ultime notizie
Bioventus’ Cut Losses 46%, Organic Sales Up 5% - Orthopedics This Week
Millennium Management LLC Sells 60,811 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
Janus Henderson Group PLC Acquires Shares of 17,200 Bioventus Inc. (NYSE:BVS) - Defense World
Balyasny Asset Management L.P. Invests $133,000 in Bioventus Inc. (NYSE:BVS) - Defense World
BNP Paribas Financial Markets Invests $1.66 Million in Bioventus Inc. (NYSE:BVS) - Defense World
Price T Rowe Associates Inc. MD Has $160,000 Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
(BVS) On The My Stocks Page - news.stocktradersdaily.com
Bioventus reiterates 2025 guidance with focus on growth and profitability - MSN
Barclays PLC Has $696,000 Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus (BVS) Price Target Trimmed by Craig-Hallum Analyst | BVS Stock News - GuruFocus
Bioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call Transcript - Insider Monkey
Is Bioventus (NASDAQ:BVS) Using Too Much Debt? - simplywall.st
Bioventus First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures - Yahoo Finance
Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures By GuruFocus - Investing.com Canada
Bioventus Reports Q1 2025 Financial Performance - TipRanks
Bioventus: Q1 Earnings Snapshot - CTPost
Bioventus Earnings Call: Growth Amid Challenges - TipRanks
Financial Fitness Check: Examining Bioventus Inc (BVS)’s Key Ratios - DWinneX
Bioventus earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Bioventus Q1 2025 slides: 5% organic growth despite revenue decline, maintains guidance - Investing.com Canada
Earnings call transcript: Bioventus Q1 2025 beats EPS forecast but faces stock dip - Investing.com Nigeria
Bioventus Inc. Q1 Loss Narrows - Nasdaq
Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Bioventus (BVS) Exceeds Q1 Revenue Expectations with Strong Perf - GuruFocus
Bioventus Inc Q1 2025 Earnings: Revenue Hits $123.9M, Beating Es - GuruFocus
Bioventus (BVS) Exceeds Q1 Revenue Expectations with Strong Performance | BVS Stock News - GuruFocus
Bioventus reports Q1 revenue and earnings above estimates, shares dip By Investing.com - Investing.com Nigeria
Bioventus reports Q1 revenue and earnings above estimates, shares dip - Investing.com Australia
Bioventus Reports First Quarter Financial Results | BVS Stock Ne - GuruFocus
Bioventus Reports First Quarter Financial Results - The Manila Times
Bioventus Reports First Quarter Financial Results | BVS Stock News - GuruFocus
Bioventus Inc. Reports Q1 2025 Financial Results: Revenue Decline of 4.3% but Organic Growth of 5.0% and Improved Non-GAAP EPS - Nasdaq
Bioventus Inc. SEC 10-Q Report - TradingView
(BVS) Trading Report - news.stocktradersdaily.com
Examining the Future: Bioventus's Earnings Outlook - Nasdaq
Bioventus Inc (BVS) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
Bioventus Inc expected to post earnings of 2 cents a shareEarnings Preview - TradingView
Legal & General Group Plc Raises Position in Bioventus Inc. (NYSE:BVS) - Defense World
Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix Medical, Bioventus - openPR.com
Bioventus Q1 2025 Earnings Preview: Key Metrics and Business Updates Coming May 6 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
LPL Financial LLC Has $433,000 Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
Alliancebernstein L.P. Sells 3,500 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
SEC Form DEFA14A filed by Bioventus Inc. - Quantisnow
Bioventus Inc Azioni (BVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):